These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7072146)

  • 1. Attempts at the autologous prevention and therapy of experimental cancer.
    Nastac E; Stoian M; Hozoc M; Chira M
    Virologie; 1982; 33(1):17-21. PubMed ID: 7072146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Different immunological factors in the therapy of an experimental tumor].
    Nicolin A; Frontini E; Olivani P
    Boll Ist Sieroter Milan; 1971; 50(4):295-8. PubMed ID: 5163498
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival of host mice and induced resistance to transplantable ascites tumors.
    Kimura Y; Tanino T
    Jpn J Exp Med; 1966 Aug; 36(4):371-405. PubMed ID: 4291054
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the problem of tumor immunology. II].
    Speiser P; Karrer K
    Krebsarzt; 1965; 20(5):335-40. PubMed ID: 5857124
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the electrophoretic mobility of mouse lymphocytes, thymocytes, macrophages and tumour cells following immunisation.
    Hartveit F; Cater DB; Mehrishi JN
    Br J Exp Pathol; 1968 Dec; 49(6):634-47. PubMed ID: 5706992
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity against the Ehrlich ascites carcinoma produced by bacterial endotoxins.
    Hager EB; Bailey GL; Hampers CL; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):124-5. PubMed ID: 4944208
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
    Häkkinen I; Halonen P
    J Natl Cancer Inst; 1971 Jun; 46(6):1161-7. PubMed ID: 4325929
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor polypassage at short intervals, a new method in experimental cancer.
    Costăchel O; Popp I
    Arch Immunol Ther Exp (Warsz); 1967; 15(5):770-80. PubMed ID: 5595078
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response against apparently host-compatible transplantable tumors.
    Manson LA; Goldstein L; Thorn R; Palmer J
    Transplant Proc; 1975 Jun; 7(2):161-4. PubMed ID: 1129841
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunity and tumors].
    Michelazzi L
    Boll Ist Sieroter Milan; 1971; 50(3):185-91. PubMed ID: 4337946
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice.
    Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P
    Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
    Tanino T
    Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of mice from malignant tumor implants by enucleated tumor cells.
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1974 Oct; 53(4):1175-6. PubMed ID: 4372368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transfer of labelled mononuclear cells from lymphatic organs to tumor hosts].
    Dvorák R; Lindner J
    Verh Dtsch Ges Pathol; 1970; 54():203-12. PubMed ID: 4104531
    [No Abstract]   [Full Text] [Related]  

  • 16. Further studies on tumor-specific immunity induced by nontumorigenic mouse ascites tissue-culture cells.
    Eng CP; Morgan JF
    Can J Microbiol; 1972 Jun; 18(6):775-81. PubMed ID: 4338315
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance and susceptibility to tumours. 3. Effect of some derivatives from immunized animals on the Bo4 and Ehrlich carcinomas.
    Dvorák R; Chlumecký J
    Neoplasma; 1969; 16(6):613-24. PubMed ID: 5369028
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
    Hayashi S
    Acta Med Okayama; 1976 Jun; 30(3):197-208. PubMed ID: 136871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On a simple method of "immunization" against cancer--an expanded reproduction attempt].
    Schmidt F
    Krebsarzt; 1968; 23(2):91-3. PubMed ID: 4301924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.